rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
To compare the intraocular pressure (IOP) reducing effect and safety of latanoprost 0.005% once daily with unoprostone 0.12% twice daily in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0161-6420
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
259-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11158796-Adult,
pubmed-meshheading:11158796-Aged,
pubmed-meshheading:11158796-Aged, 80 and over,
pubmed-meshheading:11158796-Antihypertensive Agents,
pubmed-meshheading:11158796-Dinoprost,
pubmed-meshheading:11158796-Double-Blind Method,
pubmed-meshheading:11158796-Female,
pubmed-meshheading:11158796-Glaucoma, Open-Angle,
pubmed-meshheading:11158796-Humans,
pubmed-meshheading:11158796-Intraocular Pressure,
pubmed-meshheading:11158796-Male,
pubmed-meshheading:11158796-Middle Aged,
pubmed-meshheading:11158796-Ocular Hypertension,
pubmed-meshheading:11158796-Ophthalmic Solutions,
pubmed-meshheading:11158796-Prostaglandins F, Synthetic,
pubmed-meshheading:11158796-Safety,
pubmed-meshheading:11158796-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension.
|
pubmed:affiliation |
Glaucoma Service, Department of Ophthalmology and Otolaringology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|